The human gut is colonized by a complex microbiota with multiple benefits. Although the surfaceattached, mucosal microbiota has a unique composition and potential to influence human health, it remains difficult to study in vivo. Therefore, we performed an in-depth microbial characterization (human intestinal tract chip (HITChip)) of a recently developed dynamic in vitro gut model, which simulates both luminal and mucosal gut microbes (mucosal-simulator of human intestinal microbial ecosystem (M-SHIME)). Inter-individual differences among human subjects were confirmed and microbial patterns unique for each individual were preserved in vitro. Furthermore, in correspondence with in vivo studies, Bacteroidetes and Proteobacteria were enriched in the luminal content while Firmicutes rather colonized the mucin layer, with Clostridium cluster XIVa accounting for almost 60% of the mucin-adhered microbiota. Of the many acetate and/or lactate-converting butyrate producers within this cluster, Roseburia intestinalis and Eubacterium rectale most specifically colonized mucins. These 16S rRNA gene-based results were confirmed at a functional level as butyryl-CoA:acetate-CoA transferase gene sequences belonged to different species in the luminal as opposed to the mucin-adhered microbiota, with Roseburia species governing the mucosal butyrate production. Correspondingly, the simulated mucosal environment induced a shift from acetate towards butyrate. As not only inter-individual differences were preserved but also because compared with conventional models, washout of relevant mucin-adhered microbes was avoided, simulating the mucosal gut microbiota represents a breakthrough in modeling and mechanistically studying the human intestinal microbiome in health and disease. Finally, as mucosal butyrate producers produce butyrate close to the epithelium, they may enhance butyrate bioavailability, which could be useful in treating diseases, such as inflammatory bowel disease.
Introduction
The human colon is colonized by a complex microbiota, mostly (490%) consisting of Bacteroidetes and Firmicutes (Eckburg et al., 2005; Claesson et al., 2011; Walker et al., 2011) . Beneficial contributions of this microbiota to human health include the breakdown of otherwise indigestible food compounds (Koropatkin et al., 2012) and regulation of host metabolism (Backhed et al., 2005) . Furthermore, the importance of the intestinal mcrobiota follows from the number of diseases that have been correlated with a dysbiosed microbial composition, such as inflammatory bowel diseases (IBDs; Willing et al., 2009; Walker et al., 2011) or obesity (Turnbaugh et al., 2006) . A novel focus in gut microbiology is to not only study microbes in the intestinal content but also those that colonize the mucus layer (Swidsinski et al., 2008; Van den Abbeele et al., 2011c; Belzer and de Vos, 2012) . The rationale is that mucosal microbes can interact more closely with the epithelium than their luminal counterparts, which may be crucial for achieving immunomodulatory effects. Moreover, by locally excreting antimicrobials or competing with pathogens, mucosal microbes more effectively limit pathogen translocation. Besides host immune effectors (Lievin-Le Moal and Servin, 2006) , microbial properties, such as mucus adhesion (Roos and Jonsson, 2002) or the ability to degrade host-derived glycans (Derrien et al., 2004) , also impact the distinct surface-attached microbial composition, generally characterized by an enrichment of Firmicutes (especially Clostridium cluster XIVa) over Bacteroidetes (Eckburg et al., 2005; Frank et al., 2007; Hill et al., 2009; Shen et al., 2010; Willing et al., 2010; Hong et al., 2011; Nava et al., 2011) . Moreover, the mucus layer is persistently colonized by all types of hydrogenotrophs: methanogenic archaea, sulphate-reducing bacteria and acetogenic bacteria (Nava et al., 2012) .
Despite their physiological relevance, human studies are often limited to faecal samples, which do not provide information on this mucosal microbiota. For this purpose, biopsies need to be collected, but given the invasive sampling procedures, these are often only taken at the end of an experiment, preventing dynamic monitoring or detailed mechanistic studies (Zoetendal et al., 2002) . By contrast, in vitro studies have the advantage that they are well-suited to perform mechanistic research. However, the current models generally only provide short-term information and often ignore the interaction between luminal and mucosal microbes. Recently, a long-term dynamic in vitro model was developed, which accounts for both the luminal and mucosal microbiota (mucosalsimulator of human intestinal microbial ecosystem (M-SHIME); Van den Abbeele et al., 2011b) . The simulated mucosal environment consisted of carrier material coated with commercial pig gastric mucins. When focussing on Lactobacilli, it was found that, in correspondence with in vivo data, this in vitro mucosal environment was colonized by specific Lactobacillus species (L. mucosae and L. rhamnosus GG). However, the overall microbial community shifts remain to be elucidated.
Therefore, the aim of this study was to perform an in-depth analysis of the in vitro mucosal M-SHIME microbiota using the human intestinal tract chip (HITChip), a recently developed and widely used phylogenetic micro-array (Jonkers et al., 2009; Rajilic-Stojanovic et al., 2009; Van den Abbeele et al., 2011a) . Each experiment was conducted with samples from different human subjects to account for the inter-individual variability. The aims were to determine whether the inter-individual differences among human subjects can be preserved in the model, to determine the distinct composition of the mucosal microbiota compared with the luminal one and to assess the main metabolic activities of mucosal microbes. By comparing these results with recent in vivo data and results obtained with conventional in vitro models without surfaceattached bacteria, the novel M-SHIME model was validated.
Materials and methods
Chemicals and preparation of growth media Unless stated otherwise, chemicals were obtained from Sigma (Bornem, Belgium). The experiments were conducted using sugar-depleted nutritional medium containing (in g l À 1 ) yeast extract (3.0), peptone (1.0), commercial pig gastric mucin (4.0) and cystein (0.5). Pancreatic juice contained (in g l À 1 ) NaHCO 3 (12.5), bile salts (6.0; Difco, Bierbeek, Belgium) and pancreatin (0.9). Mucin agar was prepared by boiling dH 2 O containing 5% commercial pig gastric mucin and 1% agar. The pH was adjusted to 6.8 with 10 M NaOH.
Dynamic in vitro gut model for the luminal and mucosal microbiota (M-SHIME) Although the conventional luminal (L)-SHIME (registered trademark, Ghent University-Prodigest, Ghent, Belgium) only simulates luminal microbes (Van den Abbeele et al., 2010) , the M-SHIME also contains a niche for surface-attached microbes ( Figure 1a ; Van den Abbeele et al., 2011b) . Briefly, microcosms (K1-carrier, AnoxKaldnes AB, Lund, Sweden) were submerged in mucin agar and combined in a polyethylene netting (Zakkencentrale, Rotterdam, The Netherlands). At the start of each experiment, 500 ml nutritional medium and 100 mucin-covered microcosms were added to each colon unit, followed by inoculation with 40 ml of a 1:5 dilution of fresh stools of a healthy human volunteer (Possemiers et al., 2004) . After an initial incubation of 18 h, 140 ml nutritional medium and 60 ml pancreatic juice were supplied to each colon compartment three times per day. The M-SHIME was at 37 1C and kept anaerobic by flushing twice per day for 15 min with N 2 .
Based on earlier studies, several factors were modified to optimally study mucin-adhered microbes. (i) Long-term M-SHIME studies have demonstrated that regular replacement of microcosms, results in wash-out of mucin-adhered microbes, probably due to limited cross-contamination between old and new microcosms (unpublished results). Therefore, we performed short-term experiments (3 days), which avoids renewal of microcosms. (ii) Because such short-term studies are confronted by a strong build-up of gasses and acids due to fermentation of sugar-rich nutritional medium, we used sugar-depleted medium, which allowed a more moderate carbohydrate fermentation upon inoculation. (iii) Thirdly, instead of operating two SHIME units which each consist of an ascending, transverse and descending colon (Van den Abbeele et al., 2010), we used the six colon vessels as separate units allowing to test more conditions. (iv) Finally, the pH of each unit was maintained between 6.15 and 6.4 (Btransverse colon).
Experimental design
In the first/main experiment, the overall mucinadhered microbiota composition was characterized.
Clostridium cluster XIVa species colonize mucins P Van den Abbeele et al Therefore, five M-SHIME units were inoculated with stools of different human subjects: donor A (male, 26 years), B (male, 33 years), C (male, 32 years), D (male, 24 years) and E (female, 32 years; Figure 1a ). Samples for short-chain fatty acid (SCFA) analysis were collected after 18, 42 and 68 h. Samples of the inocula together with mucosal and luminal samples of the final time point (68 h) were snap-frozen in liquid nitrogen for microbial characterization (denaturing gradient gel electrophoresis (DGGE), HITChip) and a clone library for the butyryl-CoA:acetate-CoA transferase gene.
To validate results of this main experiment, two additional experiments were performed. In the second experiment, the contribution of mucosal microbes to the overall microbial activity and composition was evaluated. Therefore, three M-SHIMEs (with mucosal environment) and three L-SHIMEs (without mucosal environment) were simultaneously inoculated with faecal inocula of donors A, B and D (Supplementary Figure S1A) . In the third experiment, the impact of the presence of mucins in the mucosal environment on mucosal microbial activity and composition was evaluated. Therefore, microcosms were coated with mucincontaining or mucin-free agar. In this way, two colon units with a mucosal environment containing mucins (M( þ )-SHME), two colon units with a mucosal environment free of mucins (M( À )-SHME) and two units without a mucosal environment (L-SHIME) were inoculated with faecal samples of donors A and D (Supplementary Figure S2A) . Samples for SCFA analysis were collected after 18, 42 and 68 h. Samples of the inocula together with mucosal and luminal samples of the final time point were subjected to DGGE. Microbial community (DGGE and HITChip) and metabolic activity analysis (SCFA) The most prominent shifts within the microbiota were monitored via DGGE. After DNA extraction (Boon et al., 2003) and PCR (Muyzer et al., 1993) , gels were run using an Ingeny PhorU apparatus (Ingeny International, Goes, The Netherlands). Pearson correlation and UPGMA (Unweighted Pair Group Method using Arithmetic Mean) clustering were used to calculate dendrograms using BioNumerics v5.10 (Applied Maths, Sint-Martens-Latem, Belgium). The HITChip was used for deep characterization of the microbiota during the first/main experiment (Rajilic-Stojanovic et al., 2009) . The array contains duplicated sets of 4800 16S rRNA oligonucleotide probes targeting 1140 intestinal phylotypes (o98% identity) and 131 genus-like groups (o90% identity). Quantification of these groups has been validated with fluorescence in situ hybridization, quantitative PCR and 454 pyrosequencing (Rajilic-Stojanovic et al., 2009; Claesson et al., 2011; van den Bogert et al., 2011) . Briefly, 16S rRNA genes were amplified, in vitro transcribed, labelled with Cy3/Cy5 and hybridized to the microarray, washed and scanned. Spot intensities were extracted using Agilent Feature Extraction software v9.5 and normalised using R-based scripts (http://www.r-project.org/). Analysis were performed in a custom-designed relational database, which runs under MySQL database management system (http:// www.mysql.com/) using a series of custom R-scripts as described previously (Rajilic-Stojanovic et al., 2009) .
Acetate, propionate, butyrate, valerate, caproate and branched SCFA (isobutyrate, isovalerate and isocaproate) were measured as described previously (De Weirdt et al., 2010) .
Clone library for butyryl-CoA:acetate CoA-transferase gene DNA was amplified with primers BCoATscrF/ BCoATscrR (2.5 mM) (Louis and Flint, 2007) . PCR products were cut from a gel, purified (QIAquick Gel Extraction Kit, QIAGEN, Antwerp, Belgium) and cloned with a TOPO TA Cloning Kit with pCR2.1-TOPO Vector (Invitrogen, Carlsbad, CA, USA). Clones were amplified with primers M13F/M13R and sequenced (AGOWA, Berlin, Germany). Sequences (B480 bp) were manually inspected and compared with databases at the NCBI website (http://blast.ncbi. nlm.nih.gov/blast.cgi). Further, they were aligned using the ClustalW algorithm with the ClustalW 1.6 weight matrix and a neighbour-joining tree with 2500 bootstrap iterations and the Kimura 2-parameter substitution model was constructed (MEGA5), using the 4-hydroxybutyrate CoA-transferase sequence from A.caccae L1-92 as outgroup. Sequences with o98% similarity to the 32 operational taxonomic units (OTUs) described by Louis et al. (2010) were considered as novel OTUs. Sequences have been submitted to the European Nucleotide Archive under accession numbers HE984158-HE984296.
Statistics
All data were analyzed using SPSS16 (SPSS Inc., Chicago, IL, USA). Normality and homogeneity of variances were studied with a Kolmogorov-Smirnov and Levene test, respectively. If so, an analysis of variance with Bonferroni test was performed to investigate intergroup differences, otherwise a Kruskal-Wallis with Mann-Whitney test was applied.
A singular value decomposition was performed to identify which factors most strongly determined the microbial differences measured with the HITChip. These factors consisted of three locations (faecal inocula, lumen, mucin layer) and five sources (donor A/B/C/D/E). The initial matrix X consisted of 131 ( ¼ s) rows representing abundances of 131 genus-like groups and 15 ( ¼ t) columns representing the 15 samples, being organized as follows: five inocula, five luminal M-and five mucosal M-SHIME samples, each time for donor A-E. Each column was converted to ranks and this rank-transformed matrix, X R , was decomposed in 15 terms each consisting of a singular value (l j ), vector u j (length s) and vector v j t (length t):
The 15 terms are ordered so that l 1 Xl 2 XyXl 15 . Hence, the first term is the most important in the approximation of X R , the second term the second most important, and so on. The significance of the contribution of location and source was verified by applying analysis of variance F-tests. Corresponding p-values (pL and pS) were computed based on a Monte Carlo approximation of the exact permutation null distributions.
To assess correlation of microbial groups detected by HITChip with human inocula, mucin layer or lumen, redundancy analysis was used as implemented in Canoco for Windows 4.5. Average signal intensities for 131 genus-like groups were used as microbial data, and diagrams were plotted using the CanoDraw for Windows utility. The Monte Carlo Permutation Procedure was used to assess statistical significance of the variation in data sets in relation to sample origin.
Results
In vitro mucosal environment enhances butyrate production SCFA were analyzed in the luminal content of M-SHIME units of five different human subjects ( Figure 1a ). As observed from the low standard errors, SCFA levels were similar among individuals (Table 1) . Sixty-eight hours after inoculation, the acetate/propionate/butyrate ratio of the M-SHIME was 65/15/20, while for conventional models without surface-attached bacteria such as the L-SHIME, ratios of around 68/25/6 have been reported (Van den Abbeele et al., 2010) . Simulating the mucosal environment thus seems to enhance butyrate levels.
Compared with the conventional L-SHIME, the novel M-SHIME not only differed in the incorporation of a simulated mucosal environment but also in a shorter incubation time, sugar-depleted nutritional medium and a single-stage fermentation. To eliminate influence of the latter and straightforwardly evaluate the impact of a mucosal environment, three M-SHIME and three L-SHIME units were simultaneously inoculated with faeces of three donors (Supplementary Figure S1A) . It followed that from the second day after inoculation onwards, the mucin layer induced a proportional shift from acetate ( À 6.3%) to butyrate ( þ 3.9%) (Supplementary Table S1 ). In a third experiment, the importance of the presence of mucins in the mucosal environment was evaluated (Supplementary Figure S2A) . It followed that the shift from acetate to butyrate was more profound when the microcosms were coated with mucin-containing as opposed to mucin-free agar (only À 2.6% acetate and þ 0.9% butyrate; Supplementary Table S2) .
Distinct microbial composition of human faeces, lumen and mucin layer (DGGE)
To observe the main microbial shifts upon inoculation of the M-SHIME, DGGE was performed on 16S rRNA amplicons of the total bacterial community (Figure 1b) . The profiles were grouped as three separate clusters according to sample origin: human inocula, lumen and mucin layer. Based on the Pearson correlation coefficients, it followed that the mucin-adhered microbiota was very different from the luminal microbiota (only 19 ± 5% similar). Furthermore, although similar shifts were observed for the different human donors (Supplementary Figure S3) , there was significant inter-individual variability among their faecal inocula (62±3% similar), which continued to exist in the luminal (64 ± 5% similar) and mucin-adhered (44 ± 7% similar) M-SHIME microbiota.
Also the DGGE profiles of the second (Supplementary Figure S1B) and third (Supplementary Figure S2B ) experiment revealed clustering according to sample origin (inocula, lumen and mucin layer) rather than to the donor (Supplementary Figures S4 and S5 ). Both experiments confirmed the distinct nature of the luminal and mucosal communities (only 14 ± 6% similar), together with the inter-individual variability among human inocula and resulting luminal and mucosal microbiota. Both experiments also showed that the luminal microbiota of the L-and M-SHIME are highly similar (90 ± 4% similar), suggesting that the mucosal environment does not majorly affect microbial composition in the luminal content ( Supplementary Figures S1B and S2B) . From the third experiment, it followed that the presence of mucins in the mucosal environment is crucial for the mucosal microbiota development. Although the microbiota that colonized the mucin-free microcosms was different from the luminal microbiota (63 ± 1% similar), the microbiota that colonized the mucin-containing microcosms was much more distinct from the luminal microbiota (only 25±5% similar; Supplementary Figure S2B) .
In vitro gut model preserves the specific interindividual differences (HITChip) In order to decipher the factors that influence microbial colonization in the M-SHIME, a singular value decomposition was applied on the highresolution phylogenetic HITChip data of the five human inocula and five luminal and mucosal M-SHIME samples. The first two terms in the decomposition explained 39.6% and 28.4% of the variation in the microbial dataset, caused by the distinct microbial composition of the human inocula, lumen and mucin layer (Table 2 and Supplementary Figure S6) . The next four terms also explained a significant part of the microbial changes (in total, 21.6%). Interestingly, these changes were independent of the location but attributed to the inter-individual differences among human subjects, indicating that the individual-specific microbial patterns are preserved in both the luminal and mucosal M-SHIME environment.
Detailed characterization of luminal and mucosal M-SHIME microbiota (HITChip) Not only did the HITChip data confirm the distinct microbial composition of the human inocula as opposed to the lumen and mucin layer of the M-SHIME (Supplementary Figure S7) , it also provided a detailed phylogenetic characterization (Figure 2 and Supplementary Table S3). The 2.9 ± 1.1 7.8 ± 1.7 11.3 ± 1.1 9.9 ± 0.7 Valerate 0.6 ± 0.1 1.9 ± 1.1 2.4 ± 0.9 1.6 ± 0.6 Caproate 0.5 ± 0.2 0.3 ± 0.3 0.5 ± 0.5 0.3 ± 0. 8.8 ± 1.7 5.4 ± 1.4 6.5 ± 1.3 4.7 ± 1.1
Abbreviations: M-SHIME, mucosal-simulator of human intestinal microbial ecosystem; SCFA, short-chain fatty acid.
Firmicutes phylum was significantly enriched in the mucin layer (94% of the total community) as opposed to the lumen (64%), attributed to increased levels of Bacilli (3%) and bacteria belonging to the Clostridium clusters I (10%), IV (19%), XI (2%) and especially Clostridium cluster XIVa (59%). By contrast, the mucin layer was virtually devoid of Bacteroidetes (4%) and Proteobacteria (1%), which rather colonized the luminal content (25% and 10%, respectively).
Butyrate-producing bacteria from Clostridum cluster XIVa colonize the mucin layer (HITChip) A redundancy analysis of the HITChip data at the bacterial group level (B131 genus-like groups) confirmed the distinct microbiota of inocula, lumen and mucin layer (P ¼ 0.02; Figure 3a ). Furthermore, it specified the microbial changes as 68 genus-like groups correlated with specific locations (Figure 3b and Supplementary Table S4 ). Of these 68 groups, 15 specifically colonized the mucin layer (all belonging to the Firmicutes), while 29 specifically correlated to the lumen (21 belonging to the Proteobacteria or Bacteroidetes). Finally, 24 bacterial groups were equally abundant between lumen and mucin layer but differed in abundance compared with the inocula. Several butyrate producers belonging to Clostridium clusters IV and XIVa, but particularly the latter, specifically colonized the mucosal M-SHIME environment (Table 3) . They include (expressed as ratio of mucin-adhered/lumen) Roseburia intestinalis (84.3), Eubacterium rectale (38.9), Papillibacter cinnamivorans (16.0), Eubacterium ventriosum (15.3), Butyrivibrio crossotus (12.8), Faecalibacterium prausnitzii (3.9), Clostridium orbiscidens (2.9) and Coprococcus eutactus (2.9). By contrast, few butyrate-producing groups specifically colonized the lumen (expressed as ratio of lumen/mucinadhered): A. caccae (4.9), Subdoligranulum variabile (2.7), Anaerotruncus colihominis (2.3) and Clostridium symbiosum (1.4).
Clone library for butyryl-CoA:acetate CoA-transferase gene confirms specific mucosal butyrate producers Overall, 45% of the sequences of the butyrylCoA:acetate CoA-transferase gene belonged to uncultured bacteria, with 16% of the sequences belonging to novel butyrate-producing species (OTU33-39). The 16S rRNA gene-derived results (HITChip) were confirmed at a functional level as the genes responsible for butyrate production were carried by different microbes in the mucin-adhered as opposed to the luminal microbiota (Figure 4 ). Although Roseburia species and an unknown species (OTU39) dominated the mucin-adhered microbiota (R. intestinalis, R. hominis and R. inulinvorans), the luminal butyrate producers mainly consisted of strain M62-1 and related unknown species (OTU24, 25 and 38). Five other uncultured butyrate producers, (distantly) related to Table 2 The singular value decomposition of the matrix containing abundances of 131 genus-like groups (as determined with the HITChip) of the human inocula, luminal and mucosal M-SHIME samples (n ¼ 5) resulted in six terms, which significantly explained the variation in the data set caused by either the location ( ¼ human inoculum, lumen M-SHIME or mucin layer M-SHIME) or source of the sample ( ¼ human donor A, B, C, D and E) The average abundance (%) of higher taxonomic groups (B phylum level) based on the HITChip analysis of the human faecal inocula and the resulting luminal and mucosal environment of the M-SHIME, 3 days after inoculation (n ¼ 5). An asterisks indicates a significant difference in the abundance between the lumen and mucin layer of the M-SHIME. The averages and s.e. can be found in Supplementary Table S3 . Clostridium cluster XIVa species colonize mucins P Van den Abbeele et al F. prausnitzii, were also detected in the luminal microbiota (OTU33-37).
Simulating a mucosal environment avoids wash-out of surface-attached bacteria The previously published HITChip data of a conventional L-SHIME without mucosal environment (Van den Abbeele et al., 2010) , showed that this setup results in an enrichment of Bacteroidetes and Proteobacteria and wash-out of Firmicutes (Supplementary Figure S8) . As the mucosal environment of the M-SHIME was specifically colonized by Firmicutes members, especially belonging to the Clostridium cluster XIVa, wash-out of these surfaceattached, mucosal Firmicutes is avoided (Figure 2 ). This was further confirmed at the bacterial group level, where HITChip analysis of the M-SHIME microbiota also allowed characterizing bacterial groups that rather colonized the mucin layer or Table 3 The abundance (%) of butyrate-producing genus-like groups belonging to Clostridium clusters IV and XIVa (oFirmicutes) that were significantly different between the luminal or mucosal M-SHIME environment, as determined with the HITChip (n ¼ 5) Figure 4 Phylogenetic tree and the amount of butyryl-CoA:acetate-CoA transferase gene sequences (B480 bp) identified in the luminal content and mucin layer of the M-SHIME 68 h after inoculation with human faecal samples of different donors (A, B and D; first experiment). Sequences with at least 98% sequence identity were grouped together under the same OTU number of which one sequence was chosen to build the phylogenetic tree. OTU numbers 432 indicate novel butyrate-producing species identified during the current study.
Bacterial group
lumen. Although bacteria characterized as luminal in the M-SHIME ( Figure 5 : area A) were maintained at high levels in the conventional L-SHIME, those characterized as mucosal in the M-SHIME ( Figure 5 : area B) disappeared from the conventional L-SHIME. Simulating a mucosal environment is thus crucial for many Firmicutes species in order to persist in an in vitro gut model.
Discussion
We recently developed the M-SHIME, an in vitro gut model, which not only provides a niche for luminal but also for surface-attached, mucosal microbes (Van den Abbeele et al., 2011b) . In this study, we confirm the inter-individual differences in microbiota composition among different human stool and mucosal samples (Zoetendal et al., 1998 (Zoetendal et al., , 2002 Eckburg et al., 2005) and demonstrate that these microbial patterns unique to each individual are preserved in the luminal and mucosal in vitro microbiota. A microarray with high phylogenetic resolution revealed the unique composition of the in vitro mucosal microbiota in great detail. The distinct microbial composition of the mucin layer, lumen and faeces was the most determining factor within the HITChip dataset accounting for 68% of the microbial differences, which was higher than the variation caused by the inter-individual differences among human subjects (21.6%; Table 2 ). The Firmicutes phylum largely dominated the mucosal M-SHIME microbiota (490%), with Clostridium cluster XIVa species accounting for 60% of the total mucosal microbiota (Figure 2) . Concordant with the fact that this cluster includes many acetate-and/or lactate-converting butyrate producers, the simulation of a mucosal environment induced a shift from acetate towards butyrate, independent of the inoculum. Despite the fact that, in living animals, the continuous desquamation of mucus into the luminal content obscures the distinction between luminal and mucosal microbes, recent in vivo studies also show an enrichment of Firmicutes (especially Clostridium cluster XIVa4 Lachnospiraceae family), over Bacteroidetes in biopsies compared with luminal or faecal samples, both in rodents (Hill et al., 2009; Nava et al., 2011) and humans (Eckburg et al., 2005; Frank et al., 2007; Shen et al., 2010; Wang et al., 2010; Willing et al., 2010; Hong et al., 2011) . This in vivo enrichment of Firmicutes in mucus, although sometimes less strong as during our in vitro study, suggests that similar forces may drive the mucosal microbiota composition in vivo and in vitro, likely to include selection of specific groups that adhere to mucins (Leitch et al., 2007) or insoluble substrates in general (Walker et al., 2008) . Furthermore, as opposed to the luminal content where the pH was maintained constant, local accumulation of acids in mucus may cause a lower pH, selecting for Firmicutes over Bacteroidetes and Proteobacteria (Duncan et al., 2009) . In addition, mucins may also serve as a growth substrate for butyrate-producing Firmicutes, possibly via cross-feeding with mucin-degrading microbes that deliver partial breakdown products, acetate and/or lactate (Belzer and de Vos 2012) , similar as reported for fructo-oligosaccharides (Belenguer et al., 2006; Falony et al., 2006) . Independent of the underlying reason, the mucus colonization by specific butyrate-producing Firmicutes (especially Clostridium cluster XIVa) species provides novel insight in the ecology of these abundant human gut colonizers.
Although bacteria belonging to Clostridium cluster XIVa, and to a lesser extent Clostridium cluster IV, were enriched in the in vitro mucosal environment, some butyrate-producing bacterial groups belonging to these clusters had higher abundances in the luminal content (Table 3 ). The most specific mucosal colonizers, as identified with the HITChip, included R. intestinalis and E. rectale, while A. caccae rather colonized the lumen. In contrast to A. caccae that is non-motile, R. intestinalis and E. rectale possess flagella, which may allow for penetration into the mucus layer . Moreover, another difference is that the mucosal butyrate producers solely require acetate and no lactate for butyrate production ), indicating that cross-feeding with other microbes might relate to the specific colonization of mucus.
The selective mucus colonization by specific butyrate-producing Firmicutes members may be Mucin colonization represents the preference of a bacterial group to colonize the in vitro mucosal environment and is expressed as the logarithm of the abundance in the mucosal environment versus the abundance in the luminal content of the M-SHIME. A value o0 indicates that the microbial group rather colonizes the lumen (area A), a value 40 indicates that this group rather colonizes the simulated mucosal environment (area B).
interconnected with processes that affect the intestinal mucus as illustrated by two examples: consumption of prebiotic compounds and IBD. Firstly, prebiotics often enhance mucus production (Ten Bruggencate et al., 2004; Van den Abbeele et al., 2011a) and, according to our findings, this may stimulate the release of mucosal butyrate producers towards the lumen. This hypothesis is supported by a study in which humanized rats were treated with long-chain arabinoxylans or inulin (Van den Abbeele et al., 2011a). Long-chain arabinoxylans increased caecal mucin levels threefold, led to higher butyrate levels and higher abundances of butyrate producers, identified as mucosal butyrate producers during this study (E. rectale and R. intestinalis). Remarkably, inulin increased caecal mucin levels by sixfold and corresponded with even higher butyrate levels and higher abundances of the same mucosal butyrate producers. Besides the selective degradation of prebiotics by specific butyrate producers Schwiertz et al., 2002) , stimulating mucus secretion may be a mechanism by which prebiotics increase butyrate levels. A second example is IBD, a disease in which the mucus layer becomes thinner and more discontinuous (Strugala et al., 2008) . Recent in vivo (Swidsinski et al., 2005; Sokol et al., 2008; Walker et al., 2011) and in vitro (Vermeiren et al., 2012) studies revealed that this disease correlates with lower levels of mucosal butyrate producers, including Roseburia and Faecalibacterium, indicating that a damaged mucus layer may lower the ecological fitness of specific butyrate producers. In vivo validation of the preference of butyrate producers to reside in mucus together with better understanding of factors that drive these processes may allow to develop novel therapies. As mucosal butyrate producers release butyrate close to the epithelium, they may enhance butyrate bioavailability for the host, which may be particularly useful for IBD patients where transport of butyrate to colonocytes is impaired (Thibault et al., 2010) . The mucosal environment of the M-SHIME prevents wash-out of microbes that disappeared from conventional in vitro models ( Figure 5 ). The enrichment of Firmicutes over Bacteroidetes and Protebacteria in the mucosal M-SHIME environment and the fact that this contributes to higher butyrate levels in the in vitro model further indicate that the M-SHIME is a significantly improved simulation of the intestinal microbiota compared with conventional in vitro models. The latter models are indeed confronted with lower abundances of Firmicutes, especially butyrate-producing species belonging to the Clostridium cluster XIVa and IV (Rajilić-Stojanović et al., 2010; Van den Abbeele et al., 2010) , whereas Bacteroidetes and Proteobacteria are very abundant (Allison et al., 1989; Macfarlane et al., 1998; Mäkeläinen et al., 2009; Rajilić-Stojanović et al., 2010; Van den Abbeele et al., 2010) , typically resulting in lower butyrate levels (Allison et al., 1989; Van den Abbeele et al., 2010) . By avoiding washout of mucosal microbes, the M-SHIME allows mechanistic studies that not only focus on planktonic but also on surface-attached microbes, increasing the relevance of in vitro research.
Although meaningful results have been obtained with the M-SHIME, several adaptations may further enhance its value. Firstly, in order to obtain a large surface area, one is currently limited to use commercially available pig gastric mucins. These mucins have lower molar mass averages and contain more impurities than freshly prepared gastric mucins (Jumel et al., 1996) . Moreover, the composition of these gastric mucin (mainly MUC1, MUC5AC and MUC6) differs from colonic mucins (mainly MUC2) and changes in gastrointestinal diseases (Reis et al., 1999; Corfield et al., 2000) . In order to improve the mucosal simulation in the M-SHIME, more relevant mucins may be used in future experiments. Ideally, human colonic mucins would be coated on the carrier materials using an agarindependent method. Next, Akkermansia muciniphila, the only known Verrucomicrobia representative that is a marker for mucin degradation (Belzer and de Vos, 2012) , did not attain high densities in the current setup. Recent studies demonstrated that Akkermansia degrades mucins in (distal) colon regions characterized by depleted nutrient levels and long residence times (Van den Abbeele et al., 2010 Abbeele et al., , 2011a . As colonization of mucus by different mucolytic species may be crucial with respect to human health (Png et al., 2010) , the M-SHIME may be improved by adding a distal colon region. Further, for performing long-term experiments, a setup needs to be designed in which mucin-covered microcosms can be regularly renewed without disturbing the stability of the mucosal and luminal microbiota, particularly without opening the vessel and exposing the micro-organisms to oxygen. Finally, microbes are confronted with an oxygen gradient in vivo as oxygen is continuously released from the blood towards the mucus layer. Accounting for this gradient would also add to the relevance of the M-SHIME.
In conclusion, the recently developed M-SHIME simulates not only planktonic but also surfaceattached gut microbes. In correspondence with in vivo studies, the simulated mucosal environment was specifically colonized by Firmicutes members, including many butyrate producers of the Clostridium cluster XIVa. Compared with conventional in vitro models that do not account for surfaceattached microbes, wash-out of the latter species was avoided resulting in a more in vivo-like microbial composition and activity, allowing for more relevant mechanistic in vitro studies to unravel the importance of mucosal gut microbes in health and disease. The M-SHIME may thus be an excellent tool to isolate novel mucosal microbes and to study factors that drive health-promoting or disease-causing microbes to reside in the mucosal microbiota from where they can closely interact with the host epithelium. The potential to isolate novel microbes was supported by the finding that 45% of the butyrate producers in the M-SHIME belonged to uncultured species. In this context, discovery of mucosal butyrate producers may lead to a novel therapy for diseases such as IBD, which are characterized by an impaired butyrate transport to the colonocytes. Further, as the microbial patterns unique to the five tested human subjects were preserved in the in vitro model, the M-SHIME may be used in future studies using larger cohorts to focus on these inter-individual differences.
